BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 3/7/2008

Intramammary Dosage Forms; Cephapirin Benzathine

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Fort Dodge Animal Health, Division of Wyeth. The supplemental NADA provides for a revision to the labeling of cephapirin benzathine intramammary infusion administered to dairy cows entering their dry period for the treatment of mastitis.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →